Accessing Database  

  •  

    DEPARTMENT OF HEALTH

    Prescription Drug Monitoring Program

    RULE NO.:RULE TITLE:

    64K-1.003Accessing Database

    NOTICE OF CHANGE

    Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 42 No. 143, July 25, 2016 issue of the Florida Administrative Register.

    The changes are in response to comments made by the Joint Administrative Procedures Committee in a letter dated August 11, 2016.  The changes are as follows:

     

    64K-1.003 Accessing Database

    (1) No change.

    (2) No change.

    (3) No change.

    (4)(a) through (c) No change.

    (4)(d) Each agency administrator may appoint authorized users to request and receive information on behalf of the agency using an “Agency Authorized User Appointment Form,” DH8015-PDMP, effective 1/2015, incorporated by reference and available at http://www.flrules.org/Gateway/reference.asp?No=Ref-06460. Prior to appointment each authorized user must review the “Training Guide for Enforcement and Investigative Agencies,” DH 8012-PDMP, effective 06/2016 1/2015, incorporated by reference and available at http://www.flrules.org/Gateway/reference.asp?No=Ref-06458, and the “E-FORCSE® Information Security and Privacy Training Course, effective 07/2016 6/2016, incorporated by reference and available at http://www.flrules.org/Gateway/reference.asp?No=Ref-06464. Certification of these reviews is required before registration can be completed. The authorized user must provide printed copies of the certifications from both courses to the agency administrator who shall maintain them for the duration of the appointment and make them available for examination upon request of the program manager. Approved authorized users will be notified by email and provided with instructions for requesting and receiving information through the secure E-FORCSE® web portal.

    (5) No change.

    (6) No change.

     

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Program Manager, Prescription Drug Monitoring Program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or Rebecca.Poston@FlHealth.gov.

Document Information

Related Rules: (1)
64K-1.003. Accessing Database